Since organic chemistry deals directly with the nature and structure of medications, as well as the nature and structure of our bodies, it is one of the major sciences in general chemistry studies and one of the most significant chemical sciences in pharmaceutical and medical studies. Organic chemistry is simply defined as the study of any compound that contains a carbon atom inside of it. There are approximately 5 million compounds in nature, of which 4.5 million are organic. In addition, a large number of other carbon-containing compounds can now be produced artificially in laboratories. It is important to note that we can also produce organic compounds (containing carbon) from inorganic compounds, as in the synthesis of organic compounds. In the synthesis of urea, as shown in the image below, urea is generated from ammonium cyanate (inorganic) by the application of heat. This illustrates how we may produce organic molecules (containing carbon) from inorganic compounds as well. Pharmaceutical organic chemistry includes analytical methods, pharmacology, metabolism, quality control, and drug chemistry in addition to illness treatments and cures. Many students studying pharmaceutical chemistry will eventually work in a lab. Pharmaceutical chemistry prepares students for professions in biotechnology, pharmaceutical firms, research institutions, and other fields.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico